Alexander Truesdell, M.D. and Alexandra Lansky, M.D. discuss four presentations originally given at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in October 2023. These presentations highlight novel approaches to high-risk percutaneous coronary intervention (PCI) risk stratification. “I think this was a really nice snapshot of contemporary practice,” Dr. Truesdell states as he highlights key points from a presentation defining characteristics of patients undergoing high-risk PCI with mechanical circulatory support (MCS). Next, Dr. Lansky discusses A-SMART-EF, a novel score for predicting mortality in patients undergoing Impella®-assisted PCI. Dr. Truesdell then discusses the impact of right ventricular dysfunction in patients undergong high-risk PCI, and Dr. Lansky concludes with data highlighting the relationship between procedural blood pressure and patient outcomes.

You must be logged in to view this content

Log in Sign up